Tudor Investment Corp ET AL decreased its stake in shares of Steris Plc (NYSE:STE) by 38.0% in the second quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 10,961 shares of the medical equipment provider’s stock after selling 6,724 shares during the quarter. Tudor Investment Corp ET AL’s holdings in Steris Plc were worth $893,000 at the end of the most recent quarter.

Several other large investors also recently modified their holdings of the stock. Bragg Financial Advisors Inc bought a new position in Steris Plc during the first quarter valued at $1,159,000. State of Wisconsin Investment Board bought a new position in Steris Plc during the second quarter valued at $1,360,000. Morgan Stanley lifted its position in Steris Plc by 28.3% during the first quarter. Morgan Stanley now owns 266,537 shares of the medical equipment provider’s stock valued at $18,514,000 after purchasing an additional 58,776 shares during the last quarter. Legal & General Group Plc lifted its position in Steris Plc by 31.0% during the first quarter. Legal & General Group Plc now owns 56,190 shares of the medical equipment provider’s stock valued at $3,902,000 after purchasing an additional 13,294 shares during the last quarter. Finally, Capstone Asset Management Co. lifted its position in Steris Plc by 36.1% during the second quarter. Capstone Asset Management Co. now owns 8,560 shares of the medical equipment provider’s stock valued at $698,000 after purchasing an additional 2,270 shares during the last quarter. Hedge funds and other institutional investors own 93.33% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: This report was first published by Watch List News and is the property of of Watch List News. If you are viewing this report on another domain, it was illegally copied and reposted in violation of United States & international copyright legislation. The legal version of this report can be viewed at https://www.watchlistnews.com/tudor-investment-corp-et-al-reduces-position-in-steris-plc-ste/1612696.html.

Several equities analysts have commented on the stock. Raymond James Financial, Inc. increased their price objective on shares of Steris Plc from $90.00 to $95.00 and gave the company an “outperform” rating in a research report on Wednesday, August 9th. Zacks Investment Research lowered shares of Steris Plc from a “buy” rating to a “hold” rating in a research report on Tuesday, August 22nd. Finally, BidaskClub lowered shares of Steris Plc from a “strong-buy” rating to a “buy” rating in a research report on Monday, July 31st. Three analysts have rated the stock with a hold rating and four have issued a buy rating to the stock. The stock presently has an average rating of “Buy” and a consensus price target of $86.75.

Steris Plc (NYSE STE) opened at 91.02 on Friday. The firm’s 50-day moving average is $86.95 and its 200 day moving average is $79.82. Steris Plc has a 52-week low of $63.80 and a 52-week high of $91.18. The company has a market cap of $7.76 billion, a price-to-earnings ratio of 65.11 and a beta of 1.29.

Steris Plc (NYSE:STE) last issued its quarterly earnings data on Tuesday, August 8th. The medical equipment provider reported $0.85 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.80 by $0.05. The firm had revenue of $608.00 million for the quarter, compared to analyst estimates of $597.66 million. Steris Plc had a net margin of 4.63% and a return on equity of 11.39%. Steris Plc’s revenue was down 4.8% on a year-over-year basis. During the same period in the previous year, the firm earned $0.79 EPS. On average, equities research analysts predict that Steris Plc will post $4.06 EPS for the current fiscal year.

The business also recently disclosed a quarterly dividend, which was paid on Thursday, September 28th. Investors of record on Tuesday, August 29th were issued a $0.31 dividend. This is a positive change from Steris Plc’s previous quarterly dividend of $0.28. This represents a $1.24 annualized dividend and a yield of 1.36%. The ex-dividend date was Friday, August 25th. Steris Plc’s payout ratio is 88.57%.

In related news, Director Mohsen Sohi sold 2,744 shares of the business’s stock in a transaction dated Wednesday, August 9th. The shares were sold at an average price of $85.98, for a total value of $235,929.12. Following the sale, the director now directly owns 21,816 shares in the company, valued at approximately $1,875,739.68. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, VP Karen L. Burton sold 3,270 shares of the business’s stock in a transaction dated Tuesday, August 15th. The shares were sold at an average price of $85.70, for a total transaction of $280,239.00. Following the completion of the sale, the vice president now owns 11,807 shares in the company, valued at $1,011,859.90. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 172,086 shares of company stock worth $14,971,621. 2.55% of the stock is owned by insiders.

Steris Plc Company Profile

STERIS plc provides infection prevention and other procedural products and services. The Company operates through four segments: Healthcare Products, which offers infection prevention and procedural solutions for healthcare providers, including capital equipment and related maintenance, and installation services, as well as consumables; Healthcare Specialty Services, which provides a range of specialty services for healthcare providers, including hospital sterilization services, instrument and scope repairs, and linen management; Life Sciences, which offers capital equipment and consumable products, and equipment maintenance and specialty services for pharmaceutical manufacturers and research facilities, and Applied Sterilization Technologies, which offers contract sterilization and laboratory services for medical device and pharmaceutical customers and others.

Institutional Ownership by Quarter for Steris Plc (NYSE:STE)

Receive News & Ratings for Steris Plc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Steris Plc and related companies with Analyst Ratings Network's FREE daily email newsletter.